A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
Saved in:
| Title: | A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer. |
|---|---|
| Authors: | Mayer EL; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA., Tayob N; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA., Ren S; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA., Savoie JJ; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA., Spigel DR; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Sarah Cannon Research Institute, Nashville, TN, USA., Burris HA 3rd; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Sarah Cannon Research Institute, Nashville, TN, USA., Ryan PD; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Texas Oncology, The Woodlands, TX, USA., Harris LN; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; National Cancer Institute, Bethesda, MD, USA., Winer EP; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.; Yale Cancer Center, New Haven, CT, USA., Burstein HJ; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. Hal_Burstein@dfci.harvard.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Feb; Vol. 204 (1), pp. 123-132. Date of Electronic Publication: 2023 Nov 29. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-023-07167-9 |
